Alternative Approach to Single-Scan Estimation of Cerebral Glucose Metabolic Rate Using Glucose Analogs, with Particular Application to Ischemia

No abstract is available for this paper.

• Publication year

  1984

• Venue

  Journal of Cerebral Blood Flow and Metabolism

• Publication date

  1984-03-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1038/jcbfm.1984.5PMID 6607260
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Alternative formula for glucose utilization using labeled deoxyglucose.

  1982cited by this paper
• Use of 2-Deoxy-D[1-11C]Glucose for the Determination of Local Cerebral Glucose Metabolism in Humans: Variation within and between Subjects

  1982cited by this paper
• Cerebral blood flow using PET measurements of fluoromethane kinetics.

  1981cited by this paper
• Error Sensitivity of Fluorodeoxyglucose Method for Measurement of Cerebral Metabolic Rate of Glucose

  1981cited by this paper
• Effect of Ischemia on Quantification of Local Cerebral Glucose Metabolic Rate in Man

  1981cited by this paper
• Noninvasive determination of local cerebral metabolic rate of glucose in man.

  1980cited by this paper
• Tomographic measurement of local cerebral glucose metabolic rate in humans with (F‐18)2‐fluoro‐2‐deoxy‐D‐glucose: Validation of method

  1979cited by this paper
• The [18F]Fluorodeoxyglucose Method for the Measurement of Local Cerebral Glucose Utilization in Mane

  1979cited by this paper
• THE [14C]DEOXYGLUCOSE METHOD FOR THE MEASUREMENT OF LOCAL CEREBRAL GLUCOSE UTILIZATION: THEORY, PROCEDURE, AND NORMAL VALUES IN THE CONSCIOUS AND ANESTHETIZED ALBINO RAT 1

  1977cited by this paper

• WSB.APP/PS1 mice develop age-dependent cerebral amyloid angiopathy, cerebrovascular deficits, and white matter damage, which are modified by humanized APOE alleles

  2025cites this paper
• Multimodality imaging of neurodegenerative disorders with a focus on multiparametric magnetic resonance and molecular imaging

  2023cites this paper
• Automatic covariance pattern analysis outperforms visual reading of 18F‐fluorodeoxyglucose‐positron emission tomography (FDG‐PET) in variant progressive supranuclear palsy

  2023cites this paper
• Lower brain glucose metabolism in normal ageing is predominantly frontal and temporal: A systematic review and pooled effect size and activation likelihood estimates meta‐analyses

  2022cites this paper
• Image-based biomedical data modeling and parametric imaging

  2020cites this paper
• A Pioneering Paper That Provided a Tool for Accurate, Observer-Independent Analysis of 18F-FDG Brain Scans in Neurodegenerative Dementias.

  2020cites this paper
• Comparison of analytical methods of brain [18F]FDG-PET after severe traumatic brain injury.

  2017cites this paper
• The radical scavenger edaravone improves neurologic function and perihematomal glucose metabolism after acute intracerebral hemorrhage.

  2015cites this paper
• Automated Identification of Dementia Using FDG-PET Imaging

  2014cites this paper
• The role of PET quantification in neurological imaging: FDG and amyloid imaging in dementia

  2014cites this paper
• Glucose metabolism in normal aging and Alzheimer’s disease: methodological and physiological considerations for PET studies

  2013cites this paper
• Multifold Bayesian Kernelization in Alzheimer's Diagnosis

  2013cites this paper
• The quantification with FDG as seen by a physician.

  2013cites this paper
• Back to the future: the absolute quantification of cerebral metabolic rate of glucose

  2013cites this paper
• Multiscale and multiorientation feature extraction with degenerative patterns for 3D neuroimaging retrieval

  2012cites this paper
• Perfusion and metabolism imaging studies in Parkinson's disease.

  2012cites this paper
• Glucose metabolism in small subcortical structures in Parkinson’s disease

  2012cites this paper
• Fluorodeoxyglucose (FDG) Positron Emission Tomography (PET)

  2012cites this paper
• Volumetric Congruent Local Binary Patterns for 3 D Neurological Image Retrieval

  2011cites this paper
• Generalized regional disorder-sensitive-weighting scheme for 3D neuroimaging retrieval

  2011cites this paper
• Localized functional neuroimaging retrieval using 3D discrete curvelet transform

  2011cites this paper
• A Multi-Center Randomized Proof-of-Concept Clinical Trial Applying [18F]FDG-PET for Evaluation of Metabolic Therapy with Rosiglitazone XR in Mild to Moderate Alzheimer's Disease

  2011cites this paper
• GA and AdaBoost-Based Feature Selection and Combination for Automated Identification of Dementia Using FDG-PET Imaging

  2011cites this paper
• Optimized pathological and visual content-based neuroimaging retrieval

  2011cites this paper
• Kinetic modelling using basis functions derived from two-tissue compartmental models with a plasma input function: General principle and application to [18F]fluorodeoxyglucose positron emission tomography

  2010cites this paper
• 3D neurological image retrieval with localized pathology-centric CMRGlc patterns

  2010cites this paper
• Tracer Kinetic Modeling: Methodology and Applications

  2010cites this paper
• A robust volumetric feature extraction approach for 3D neuroimaging retrieval

  2010cites this paper
• Redistribution of whole-body energy metabolism by exercise: a positron emission tomography study

  2009cites this paper
• Transient focal increase in perihematomal glucose metabolism after acute human intracerebral hemorrhage.

  2009cites this paper
• Techniques for Parametric Imaging

  2008cites this paper
• Classification of dementia from FDG-PET parametric images using data mining

  2008influential citation
• Genetic algorithm-based PCA eigenvector selection and weighting for automated identification of dementia using FDG-PET imaging.

  2008cites this paper
• Tracer Kinetic Modeling in PET.

  2007cites this paper
• Tracer Kinetic Modeling in Nuclear Medicine: Theory and Applications

  2006cites this paper
• Positron Emission Tomography

  2006cites this paper
• Glucose Consumption and Rate Constants for <SUP> 18</SUP>F-fluorodeoxyglucose in Human Gliomas

  2006cites this paper
• Tracer Kinetic Modeling in PET

  2005cites this paper
• Visual hallucination in Parkinson's disease with FDG PET

  2004cites this paper
• Spinocerebellar Ataxia Type 1 with-Multiple and Glial System Degeneration n 1 * T 1 . Lytoplasmc lnclusions

  2004cites this paper
• Metabolic rates in small brain nuclei determined by high-resolution PET.

  2004cites this paper
• Cognitive- and motor-related regions in Parkinson's disease: FDOPA and FDG PET studies

  2004cites this paper
• Quantitative Assay Development for PET

  2004cites this paper
• Positron emission tomography in central nervous system drug discovery and development.

  2003cites this paper
• Activation of basal ganglia loops in idiopathic Parkinson’s disease: a PET study

  2003cites this paper
• Principles of tracer kinetic analysis.

  2003cites this paper
• Measurement of glucose consumption using [(18)F]fluorodeoxyglucose.

  2002cites this paper
• Regional Brain Activation Due to Pharmacologically Induced Adrenergic Interoceptive Stimulation in Humans

  2002cites this paper
• Neural Activation and Glucose Metabolism in Hemodynamic Ischemia

  2001cites this paper
• In-vivo measurements of regional acetylcholine esterase activity in degenerative dementia: comparison with blood flow and glucose metabolism

  2000cites this paper
• Noninvasive estimation of FDG input function for quantification of cerebral metabolic rate of glucose: optimization and multicenter evaluation.

  2000cites this paper
• Glucose hypometabolism and neuropathological correlates in brains of dementia with Lewy bodies.

  2000cites this paper
• PET measures of benzodiazepine receptors in progressive supranuclear palsy

  2000cites this paper
• Three-dimensional stereotactic surface projection analysis of macaque brain PET: development and initial applications.

  2000cites this paper
• Neuropsychological function and cerebral glucose utilization in isolated memory impairment and Alzheimer's disease.

  1999cites this paper
• Motor correlates of occipital glucose hypometabolism in Parkinson’s disease without dementia

  1999cites this paper
• Parieto-occipital glucose hypometabolism in Parkinson's disease with autonomic failure.

  1999cites this paper
• Noninvasive measurement of cerebral metabolic rate of glucose using standardized input function.

  1999cites this paper
• The significance of family history status in relation to neuropsychological test performance and cerebral glucose metabolism studied with positron emission tomography in older alcoholic patients.

  1998cites this paper
• Regional cerebral glucose utilization is modulated by the dosage of apolipoprotein E type 4 allele and α1‐antichymotrypsin type A allele in Alzheimer's disease

  1997cites this paper
• A technique for extracting physiological parameters and the required input function simultaneously from PET image measurements: theory and simulation study

  1997cites this paper
• Evaluation of two population-based input functions for quantitative neurological FDG PET studies

  1997cites this paper
• Cerebral metabolic differences in Parkinson's and Alzheimer's diseases matched for dementia severity.

  1997cites this paper
• Improved Detection of Epileptic Foci with PET

  1996cites this paper
• Spinocerebellar ataxia type 1 with multiple system degeneration and glial cytoplasmic inclusions

  1996cites this paper
• Chronological positron emission tomographic study of severe diffuse brain injury in the chronic stage.

  1996cites this paper
• Diminished glucose transport and phosphorylation in Alzheimer's disease determined by dynamic FDG-PET.

  1996cites this paper
• Determination of regional rate constants from dynamic FDG-PET studies in Parkinson's disease.

  1996cites this paper
• The application of positron emission tomography to the study of the normal menstrual cycle.

  1996cites this paper
• Simplified Brain Slice Glucose Utilization

  1996cites this paper
• Irradiation effects on the metabolism of metastatic brain tumors: analysis by positron emission tomography and 1H-magnetic resonance spectroscopy.

  1996cites this paper
• Positron emission tomographic studies of cerebral benzodiazepine‐receptor binding in chronic alcoholics

  1996cites this paper
• Effects of disulfiram on positron emission tomography and neuropsychological studies in severe chronic alcoholism.

  1996cites this paper
• Fluoro-deoxyglucose positron emission tomography in diffuse Lewy body disease

  1996cites this paper
• Cerebral hemodynamics and metabolism of severe diffuse brain injury measured by PET.

  1996cites this paper
• Progressive apraxia in clinically discordant monozygotic twins.

  1995cites this paper
• Preserved Pontine Glucose Metabolism in Alzheimer Disease: A Reference Region for Functional Brain Image (PET) Analysis

  1995cites this paper
• MEASURING METABOLIC FUNCTION WITH PET: TECHNICAL CONSIDERATIONS

  1995cites this paper
• Positron emission tomography measures of benzodiazepine binding in Alzheimer's disease.

  1995cites this paper
• A comparison of cerebral blood flow and glucose metabolism in olivopontocerebellar atrophy using PET

  1995cites this paper
• An improved method to calculate cerebral metabolic rates of glucose using PET.

  1995cites this paper
• A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET.

  1995cites this paper
• PET of peripheral benzodiazepine binding sites in the microgliosis of Alzheimer's disease.

  1995cites this paper
• Patterns of cerebral glucose metabolism detected with positron emission tomography differ in multiple system atrophy and olivopontocerebellar atrophy

  1994cites this paper
• Anatomic standardization: linear scaling and nonlinear warping of functional brain images.

  1994cites this paper
• A clinically practical method to acquire parametric images of unidirectional metabolic rates and blood spaces.

  1994cites this paper
• Neural-network classification of normal and Alzheimer's disease subjects using high-resolution and low-resolution PET cameras.

  1994cites this paper
• Evaluation of the brain by positron emission tomography.

  1993cites this paper
• Positron emission tomographic (PET) studies in dementia.

  1993cites this paper
• Determination of 18F-fluoro-2-deoxy-D-glucose rate constants in the anesthetized baboon brain with dynamic positron tomography.

  1993cites this paper
• Studies of Brain Metabolism in Psychiatric Patients: Can Standards Be Drawn?

  1993cites this paper
• Cerebral Hemodynamics and Metabolism in Severe Diffuse Brain Injury in Chronic Stage: Positron Emission Tomography

  1993cites this paper
• In vivo cerebral metabolism and central benzodiazepine‐receptor binding in temporal lobe epilepsy

  1993cites this paper
• Viability of Neocortical Function Shown in Behavioral Activation State PET Studies in Alzheimer Disease

  1992cites this paper
• The FDG model and its application in clinical PET studies.

  1992cites this paper
• Uses and Limitations of Positron Emission Tomography in Clinical Pharmacokinetics/Dynamics (Part I)

  1992cites this paper
• Uses and Limitations of Positron Emission Tomography in Clinical Pharmacokinetics/Dynamics (Part II)

  1992cites this paper
• Positron emission tomography (PET) in "pure akinesia".

  1992cites this paper
• Precision and Accuracy Considerations of Physiological Quantitation in PET

  1991cites this paper
• Cerebrocerebellar Relationship during Behavioral Activation: A PET Study

  1991cites this paper